197 related articles for article (PubMed ID: 24251326)
1. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract][Full Text] [Related]
2. Patients with prostate cancer are less likely to develop oesophageal adenocarcinoma: could androgens have a role in the aetiology of oesophageal adenocarcinoma?
Cooper SC; Croft S; Day R; Thomson CS; Trudgill NJ
Cancer Causes Control; 2009 Oct; 20(8):1363-8. PubMed ID: 19455396
[TBL] [Abstract][Full Text] [Related]
3. Risk of second cancer in esophageal squamous cell carcinoma and adenocarcinoma survivors: a population-based analysis in SEER dataset.
Qi X; Su X; Wang C; Yao Q; Fan Y
Transl Gastroenterol Hepatol; 2023; 8():33. PubMed ID: 38021360
[TBL] [Abstract][Full Text] [Related]
4. Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies.
Ahsan H; Neugut AI; Gammon MD
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):779-82. PubMed ID: 9332759
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
[TBL] [Abstract][Full Text] [Related]
7. Association of esophageal adenocarcinoma with other subsequent primary cancers.
Das A; Thomas S; Zablotska LB; Neugut AI; Chak A
J Clin Gastroenterol; 2006; 40(5):405-11. PubMed ID: 16721221
[TBL] [Abstract][Full Text] [Related]
8. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
Abhyankar N; Hoskins KF; Abern MR; Calip GS
BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
[TBL] [Abstract][Full Text] [Related]
9. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer.
Shore R; Yu J; Ye W; Lagergren J; Rutegård M; Akre O; Stattin P; Lindblad M
Sci Rep; 2021 Jun; 11(1):13486. PubMed ID: 34188067
[TBL] [Abstract][Full Text] [Related]
10. Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis.
Abdel-Rahman O; Cheung WY
Curr Med Res Opin; 2017 Nov; 33(11):2009-2017. PubMed ID: 28532174
[TBL] [Abstract][Full Text] [Related]
11. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
[TBL] [Abstract][Full Text] [Related]
12. The influence of deprivation and ethnicity on the incidence of esophageal cancer in England.
Cooper SC; Day R; Brooks C; Livings C; Thomson CS; Trudgill NJ
Cancer Causes Control; 2009 Oct; 20(8):1459-67. PubMed ID: 19533393
[TBL] [Abstract][Full Text] [Related]
13. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study.
Steevens J; van den Brandt PA; Goldbohm RA; Schouten LJ
Gastroenterology; 2010 May; 138(5):1704-13. PubMed ID: 20006613
[TBL] [Abstract][Full Text] [Related]
14. Descriptive epidemiology of esophageal carcinoma in the Ohio Cancer Registry.
Cummings LC; Cooper GS
Cancer Detect Prev; 2008; 32(1):87-92. PubMed ID: 18406068
[TBL] [Abstract][Full Text] [Related]
15. Is young-onset esophageal adenocarcinoma increasing in Japan? An analysis of population-based cancer registries.
Saito E; Yano T; Hori M; Yoneoka D; Matsuda T; Chen Y; Katanoda K
Cancer Med; 2022 Mar; 11(5):1347-1356. PubMed ID: 35077026
[TBL] [Abstract][Full Text] [Related]
16. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
Wu GX; Nelson RA; Kim JY; Raz DJ
Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter.
Alexandre L; Broughton T; Loke Y; Beales IL
Dis Esophagus; 2012 Aug; 25(6):535-44. PubMed ID: 22129441
[TBL] [Abstract][Full Text] [Related]
18. Esophageal adenocarcinoma after obesity surgery in a population-based cohort study.
Maret-Ouda J; Tao W; Mattsson F; Brusselaers N; El-Serag HB; Lagergren J
Surg Obes Relat Dis; 2017 Jan; 13(1):28-34. PubMed ID: 26723560
[TBL] [Abstract][Full Text] [Related]
19. Changing pattern of esophageal cancer incidence in New Mexico.
Vega KJ; Jamal MM
Am J Gastroenterol; 2000 Sep; 95(9):2352-6. PubMed ID: 11007241
[TBL] [Abstract][Full Text] [Related]
20. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
Pawlish KS; Schottenfeld D; Severson R; Montie JE
Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
